ESTUDIO DE EXTENSIÓN DEL ESTUDIO AC-055-305 A LARGO PLAZO, ABIERTO, DE BRAZO ÚNICO PARA VALORAR LA SEGURIDAD, TOLERABILIDAD Y EFICACIA DE MACITENTAN EN SUJETOS CON EL SÍNDROME DE EISENMENGER.
Datos básicos
- Código:
- AC-055-308
- Protocolo:
- AC-055-308
- EUDRACT:
- 2012-004411-31
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Dotación:
- Año de incio:
- 2014
- Año de finalización:
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
[[en]]Peripheral access ultrafiltration in adults with complex congenital heart disease and refractory congestion.
Guerrero Cervera B; (...); Almenar Bonet L
Article. 10.1016/j.rec.2024.08.015. 2024
[Farewell open letter to SEFH members].
Editorial Material. 10.7399/fh.2015.39.6.10128. 2015
[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence
Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda
Editorial Material. 10.1016/j.farma.2024.08.009. 2024
[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Andrés JLP, Solsona MDE
Article. 10.1016/j.farma.2023.10.004. 2024
[Translated article] New challenges in advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2024.05.001. 2024
[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.12.007. 2025
[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.
Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.09.006. 2024
2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11611. 2021
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.33393/grhta.2022.2333. 2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
Zozaya, Neboa; (...); Verde, Luis
Article. 10.1017/S0266462322000459. 2022
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.
de Andrés-Nogales F; (...); Martínez-Olmos J
Article. 10.1007/s41669-020-00201-2. 2020
A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.
Casado, MA; (...); Grp MULTIDEX-EMD
Meeting Abstract. 10.1016/j.jval.2018.09.2545. 2018
A new definition and refocus of pharmaceutical care: the Barbate Document
Morillo-Verdugo R; (...); Poveda-Andrés JL
Article. 10.7399/fh.11389. 2020
A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia
Megías-Vericat JE; (...); Aliño SF
Article. 10.1038/tpj.2015.80. 2016
Activation of (1A)-adrenoceptors desensitizes the rat aorta response to phenylephrine through a neuronal NOS pathway, a mechanism lost with ageing
Arce, C; (...); Dolores Ivorra, Maria
Article. 10.1111/bph.13800. 2017
Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.
Ballesta-López O; (...); Poveda-Andrés JL
Article. 10.1177/1078155220915953. 2020
Administration of Subcutaneous Furosemide in Elastomeric Pump vs. Oral Solution for the Treatment of Diuretic Refractory Congestion.
Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis
Article. 10.1007/s40292-021-00476-4. 2021
Adult congenital heart disease in Spain: health care structure and activity, and clinical characteristics.
Oliver Ruiz JM; (...); Gallego P
Article. 10.1016/j.recesp.2019.09.007. 2020
Aflibercept in exudative age related macular degeneration refractory to ranibizumab.
Ruiz Ramos J; (...); Gallego-Pinazo R
Article. 10.1016/j.oftal.2015.07.018. 2015
Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients.
Perez-Carrillo, Lorena; (...); Rosello-Lleti, Esther
Article. 10.1097/TP.0000000000004273. 2022
Alterations in the Nucleocytoplasmic Transport in Heart Transplant Rejection.
Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis
Article. 10.1016/j.transproceed.2021.09.003. 2021
Analisis de las causas de suspension de tratamiento con triple terapia antiviral en pacientes con hepatitis C.
Ruiz Ramos J; (...); Poveda Andrés JL
Abstract of Published Item. 10.7399/fh.2014.38.3.1171. 2014
Analysing criteria for price and reimbursement of orphan drugs in Spain.
Badia, X; (...); Tort, M
Article. 10.7399/fh.11147. 2019
Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/10781552211038518. 2021
Analysis of Heart Transplant Survival According to Difference in Age Between Donor and Recipient.
Lopez-Vilella, Raquel; (...); Almenar-Bonet, Luis
Article. 10.1016/j.transproceed.2022.10.014. 2022
Analysis of heart transplantation survival according to difference in age between donor and recipient
Donoso Trenado, V.; (...); Almenar Bonet, L.
Meeting Abstract. 2022
Analysis of hospital mortality and primary graft dysfunction in urgent heart transplantation according to the type and duration of circulatory/ventricular assistance
Vilella, RRL; (...); Bonet, LA
Meeting Abstract. 2017
Analysis of the Intrahospital and Long-Term Survival of Heart Transplant Patients With a Short-Term Mechanical Assistance Device.
Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar
Article. 10.1016/j.transproceed.2021.06.030. 2021
Anidulafungin-Induced Alopecia
Ruiz-Ramos J; (...); Poveda-Andrés JL
Article. 10.1177/1060028014524534. 2014
Annual evolution of the prescription of drugs with prognostic implications in acute decompensated heart failure with reduced ejection fraction.
López-Vilella R; (...); Almenar Bonet L
Article. 10.1186/s12872-024-03728-y. 2024
Antimicrobial stewardship programme implementation in a medical ward
Ruiz, J; (...); Poveda, JL
Article. 2018
Antimicrobial stewardship programme in critical care medicine: A prospective interventional study
Ruiz, J; (...); Catellanos, A
Article. 10.1016/j.medin.2017.07.002. 2018
Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-a antagonist therapy.
Genre F; (...); González-Gay MA
Article. 2013
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).
Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ
Letter. 10.1111/jdv.19432. 2023
Assessment of the quality of sample labelling for clinical research.
Pérez-Huertas P; (...); Poveda-Andrés JL
Article. 10.7399/fh.2016.40.2.9753. 2016
Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation
Sánchez-Lázaro I; (...); Aliño SF
Article. 10.2217/pgs.15.39. 2015
Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-a antagonist therapy.
Genre F; (...); González-Gay MA
Article. 2013
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Megias-Vericat, JE; (...); Bonanad, S
Meeting Abstract. 2018
Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2018.12.027. 2019
beta 2-Adrenoceptors and GRK2 as Potential Biomarkers in Patients With Chronic Pulmonary Regurgitation
Rodriguez-Serrano, M; (...); D'Ocon, P
Article. 10.3389/fphar.2019.00093. 2019
beta(2)- and beta(1)-Adrenoceptor Expression Exhibits a Common Regulatory Pattern With GRK2 and GRK5 in Human and Animal Models of Cardiovascular Diseases
Montó F; (...); D'Ocon P
Article. 10.1097/FJC.0000000000000299. 2015
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C; (...); Hernandez D
Article. 10.1111/ctr.14550. 2022
Biosimilares: viejas polemicas con nuevos argumentos.
Poveda-Andrés JL, Bosó-Ribelles V
Editorial Material. 10.7399/fh.2015.39.3.8978. 2015
BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric Population
Perez-Huertas, P; (...); Poveda-Andres, JL
Article. 10.1177/1043454216631952. 2017
Breakthrough invasive fungal disease in high-risk hematologic malignancies in children: a single-center experience
Garcia-Robles, AA; (...); Fernandez-Navarro, JM
Meeting Abstract. 2017
CA125: a new biomarker in patients with Fontan circulation (vol 76, pg 112, 2023)
Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda
Correction. 10.1016/j.rec.2023.03.018. 2023
CA125: a new biomarker in patients with Fontan circulation.
Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda
Article. 10.1016/j.rec.2022.05.029. 2022
Calidad y Legibilidad de la Hoja de Informacion al Paciente en Estudios con Analisis Farmacogenetico.
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 2015
Can the number of Comorbidities predict readmissions for Heart Failure patients?
Ferre, MFM; (...); Almenar, L
Meeting Abstract. 2018
Carbohydrate antigen 125 and glutamic oxaloacetic transaminase as congestion markers in acute heart failure. Is there clinical association between them?
Carrillo, D; (...); Almenar, L
Meeting Abstract. 2018
Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker.
Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis
Article. 10.3390/jpm12060913. 2022
Cardiac S1P/Ceramide imbalance in human heart failure: implication of gene dysregulation
Perez Carrillo, L.; (...); Tarazon, E.
Meeting Abstract. 2021
Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy.
Alania-Torres, Edgardo; (...); Valle-Munoz, Alfonso
Case Reports. 10.3389/fcvm.2021.759119. 2021
CCSER2 and RAC3 serum expression levels detect cardiac allograft rejection
Rodriguez, J. M.; (...); Rosello-Lleti, E.
Meeting Abstract. 2021
Circulating biomarkers for the detection of the pre-capillary component in patients with pulmonary hypertension due to left heart diseases
Ferrer, JLM; (...); Bonet, LA
Meeting Abstract. 2017
Circulating long non-coding RNAs detection after heart transplantation and its accuracy in the diagnosis of acute cardiac rejection.
Pérez-Carrillo L; (...); Roselló-Lletí E
Letter. 10.1186/s40364-024-00590-0. 2024
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2021.07.009. 2021
Clinical evaluation of rituximab treatment for neuromyelitis optica
Fernández-Megía MJ; (...); Poveda-Andrés JL
Article. 10.1016/j.nrl.2014.09.001. 2015
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
Lorente Fernández L; (...); Casanova-Estruch B
Article. 10.1016/j.nrl.2013.06.014. 2014
Clinical features and outcomes of adult patients with single ventricle physiology not undergoing Fontan repair
Gordon, B; (...); Rueda, J
Meeting Abstract. 2020
Clinical outcome of COVID-19 in patients with adult congenital heart disease.
Schwerzmann M; (...); EPOCH
Article. 10.1136/heartjnl-2020-318467. 2021
Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model
Nogueras, A; (...); Calleja, MA
Letter. 10.1136/ejhpharm-2019-001905. 2019
Clinical phenotypes according to diuretic combination in acute heart failure.
Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar
Article. 10.1016/j.hjc.2023.03.009. 2023
Clinical profile of an unselected population with heart failure treated with vericiguat in real life: differences with the VICTORIA trial
Esteban-Fernandez, Alberto; (...); VERISEC Registry Researchers
Article. 10.3389/fcvm.2024.1504427. 2025
Clinical profile of heart failure patients starting vericiguat in clinical practice
Esteban Fernandez, A. Alberto; (...); Diez Villanueva, P.
Meeting Abstract. 2024
Clinical profiling of patients admitted with acute heart failure: a comprehensive survival analysis.
Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis
Article. 10.3389/fcvm.2024.1381514. 2024
Clinical Utility of the IMPACT Score for Mortality Prediction after Heart Transplantation: External Validation Study
Bautista, CDO; (...); Jimenez, JFD
Meeting Abstract. 10.1016/j.healun.2019.01.517. 2019
Clinical, echocardiographic and analytical patterns of biomarkers in cardiac amyloidosis; a real-world analysis.
Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.
Meeting Abstract. 2024
Collaborative model of home delivery program in haemophilia through an association of patients
Megias-Vericat, JE; (...); Bonanad, S
Meeting Abstract. 2018
Combining Serum miR-144-3p and miR-652-3p as Potential Biomarkers for the Early Diagnosis and Stratification of Acute Cellular Rejection in Heart Transplantation Patients.
Pérez-Carrillo L; (...); Roselló-Lletí E
Article. 10.1097/TP.0000000000004622. 2023
Combining serum miR-144-3p and miR-652-3p as potential biomarkers for the early diagnosis and stratification of acute cellular rejection in heart transplantation patients
Perez-Carrillo, L.; (...); Rosello-Lleti, E.
Meeting Abstract. 2022
COMPARATIVE ANALYSIS OF SURVIVAL OF PATIENTS WITH CONGENITAL HEART DISEASE TRANSPLANTED FROM HEART OR HEART-LUNG
Trenado, VD; (...); Almenar-Bonet, L
Meeting Abstract. 2021
Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time
Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar
Article. 10.3390/biomedicines12092109. 2024
Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo
Megias-Vericat, JE; (...); Poveda, JL
Meeting Abstract. 2020
Complications After Heart Transplantation According to the Type of Pretransplant Circulatory/Ventricular Support.
Lopez-Vilella, R; (...); Bonet, LA
Article. 10.1016/j.transproceed.2021.08.040. 2021
Comprehensive Long-Term Follow up of Adults with Arterial Switch Operation-European Collaboration for Prospective Outcome Research in Congenital Heart Disease (EPOCH-ASO)-Study Design and Protocols
Ruperti-Repilado, FJ; (...); Greutmann, M
Article. 10.32604/CHD.2020.012599. 2020
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano JB; (...); Soto-Ortega I
Article. 10.1016/j.farma.2023.01.003. 2023
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada
Article. 10.1016/j.farma.2023.04.002. 2023
Conventional and right-sided screening for subcutaneous ICD in a population with congenital heart disease at high risk of sudden cardiac death
Alonso, P; (...); Martinez, L
Article. 10.1111/anec.12461. 2017
Correlates of musculoskeletal pain and kinesiophobia in older adults with heart failure: A structural equation model.
Sentandreu-Mano, Trinidad; (...); Marques-Sule, Elena
Article. 10.1016/j.gerinurse.2023.07.003. 2023
Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-a therapy.
Genre F; (...); González-Gay MÁ
Article. 2013
Correlation of various molecules involved in cellular traffic with the severity of heart failure in patients undergoing cardiac transplantation
Ezzitouny, M.; (...); Martinez-Dolz, L.
Meeting Abstract. 2018
COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA
Gironella, M.; (...); Oyaguez, I
Meeting Abstract. 2019
COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN
Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.
Meeting Abstract. 2024
Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1080/13696998.2017.1311903. 2017
Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.
Poveda JL; (...); Torres C
Article. 10.1080/14737167.2019.1635014. 2020
COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN
Trillo, JL; (...); Torres, C
Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018
Cost-effectiveness of methoxy polyethylene glycolepoetin beta versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice
Lorente-Fernandez, L; (...); Poveda-Andres, JL
Article. 10.1136/ejhpharm-2013-000426. 2015
COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN
Bonanad, S; (...); Gonzalez-Dominguez, A
Meeting Abstract. 2020
Costs of the management of hemophilia A with inhibitors in Spain
Bonanad, S; (...); Gonzalez-Dominguez, A
Article. 10.33393/grhta.2021.2234. 2021
COVID-19 AND CARDIAC TRANSPLANTATION. EXPERIENCE IN A TERTIARY HOSPITAL
Trenado, VD; (...); Almenar-Bonet, L
Meeting Abstract. 2021
COVID-19 and Heart Transplantation. Initial Experience in a Tertiary Hospital.
Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar
Article. 10.1016/j.transproceed.2021.07.054. 2021
COVID-19 infection in heart transplants in pre- and post-vaccination periods
Donoso Trenado, V.; (...); Almenar Bonet, L.
Meeting Abstract. 2022
COVID-19 Infection in Heart Transplants in Pre- and Postvaccination Periods.
Donoso Trenado, Victor; (...); Almenar-Bonet, Luis
Article. 10.1016/j.transproceed.2022.10.005. 2022
Creatinine and NT-ProBNP levels could predict the length of hospital stay of patients with decompensated heart failure.
López-Vilella R; (...); Almenar Bonet L
Article. 10.1080/00015385.2020.1871264. 2021
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis
Megias-Vericat, JE; (...); Poveda, JL
Letter. 10.1111/hae.13733. 2019
Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products
Eduardo Megias, Juan; (...); Iorio, Alfonso
Meeting Abstract. 10.1182/blood-2019-127946. 2019
Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country
Lopez-Vilella, R.; (...); Almenar Bonet, L.
Article. 2022
CURRENT STATUS AND DEVELOPMENT OF CARDIOPULMONARY TRANSPLANTATION IN SPAIN
Lopez-Vilella, R; (...); Almenar-Bonet, L
Meeting Abstract. 2021
Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.
Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL
Editorial Material. 10.1016/j.farma.2024.08.001. 2024
Changes in Adrenoceptor and GRK Expression in Patients With Chronic Pulmonary Regurgitation.
Rodríguez-Serrano M; (...); Martínez-Dolz L
Article. 10.1016/j.rec.2018.05.030. 2019
Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design
Minana, G; (...); Myocardial-IRON Investigators
Article. 10.1002/clc.22956. 2018
Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study
Escribano-Subias, P; (...); Barbera, JA
Article. 10.1186/s12890-020-01197-5. 2020
Changes in the Treatment of Decompensated Advanced Heart Failure During Hospitalization and at Discharge.
Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis
Article. 10.1016/j.transproceed.2022.10.002. 2022
Changes over the years in the indication for heart-lung transplantation in Spain
Lopez Vilella, R.; (...); Almenar Bonet, L.
Meeting Abstract. 2022
Characterisation of iPSCs from a patient with transposition of the great arteries
Ontoria-Oviedo, I; (...); Sepulveda, P
Meeting Abstract. 2017
Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.1080/17512433.2019.1573668. 2019
De una asistencia biventricular mínimamente invasiva al implante de Heartware.
Pérez-Guillén M; (...); Torregrosa-Puerta S
Article. 10.24875/ACM.21000073. 2022
Decreased clinical performance in TGA-ASO patients after RVOT interventions; a multicenter European collaboration.
Engele LJ; (...); Bouma BJ
Article. 10.1016/j.ijcard.2024.132027. 2024
Decreased clinical performance in TGA-ASO patients after RVOT re-interventions; multicenter European collaboration
Engele, L.; (...); Bouma, B. J.
Meeting Abstract. 2023
Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project
Blade, J; (...); Lizan, L
Article. 10.1136/bmjopen-2017-018850. 2018
Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.
Salinas P; (...); Escaned J
Article. 10.1016/j.carrev.2021.11.015. 2021
Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis
Alvarez-Roman, MT; (...); Badia, X
Article. 10.1177/2284240319880534. 2019
DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Alvarez, E.; (...); Badia, F. J.
Meeting Abstract. 2019
Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
Abad, Maria Reyes; (...); Gil, Alicia
Article. 10.33393/grhta.2024.3041. 2024
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis
Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther
Article. 10.1002/jvc2.275. 2024
DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN
Poveda, J. L.; (...); Vitoria, I
Meeting Abstract. 2019
Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain
Badia, X; (...); Poved, JL
Article. 10.1080/21678707.2019.1652163. 2019
Diagnostic power of echocardiographic speckle tracking of the tricuspid annular motion to assess right ventricular dysfunction
Alonso P; (...); Salvador A
Letter. 10.1016/j.ijcard.2013.12.157. 2014
Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients.
Perez-Carrillo, Lorena; (...); Rosello-Lleti, Esther
Article. 10.1016/j.healun.2021.10.004. 2022
Differential gene expression of C-type natriuretic peptide and its related molecules in dilated and ischemic cardiomyopathy. A new option for the management of heart failure
Tarazón E; (...); Portolés M
Letter. 10.1016/j.ijcard.2014.04.037. 2014
Does the age of the recipient influence the survival of the heart transplant?
Lopez-Vilella, RLV; (...); Bonet, LABA
Meeting Abstract. 2019
Does the calcineurin inhibitor have influence on cytomegalovirus infection in heart transplantation?
Rodríguez-Serrano M; (...); Salvador-Sanz A
Article. 10.1111/ctr.12282. 2014
Does the Calcineurin Inhibitor Have Influence on Cytomegalovirus Infection in Heart Transplantation?
Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.
Article. 10.1016/j.healun.2014.01.067. 2014
Donor-derived cell-free DNA as a new biomarker for cardiac allograft rejection: A prospective study (FreeDNA-CAR).
Jimenez-Blanco, Marta; (...); Segovia-Cubero, Javier
Article. 10.1016/j.healun.2024.11.009. 2024
Donor-Derived Cell-Free DNA as a Potential Biomarker for Acute Cellular Rejection Surveillance (FreeDNA-CAR Study)
Bravo, M. Jimenez -Blanco; (...); Segovia-Cubero, J.
Meeting Abstract. 2023
Donor-Derived Cell-Free DNA Correlates Well with NT-ProBNP in Heart Transplant Recipients Undergoing Routine Endomyocardial Biopsies During First Year Post-Heart Transplant
Bravo, M. Jimenez-Blanco; (...); Segovia-Cubero, J.
Meeting Abstract. 2023
Dose banding aplicado a la elaboracion de antineoplasicos: una revision narrativa de la literatura.
Pérez Huertas P; (...); Poveda Andrés JL
Article. 10.7399/fh.2015.39.4.8839. 2015
Drug Interaction Between Oral Cyclosporine Modified and Iron
Domingo-Chiva, E; (...); Poveda-Andres, JL
Article. 10.1177/1060028013514734. 2014
Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases
Megias-Vericat, JE; (...); Poveda, JL
Review. 10.1007/s10072-017-2833-9. 2017
ECG determinants as markers of right ventricular dysfunction in patients with chronic right ventricular volume overload by congenital heart disease
Alonso Fernandez, P.; (...); Salvador, A.
Article. 2014
ECONOMIC IMPACT LINKED TO THE REDUCTION OF EXACERBATIONS WHEN A TREATMENT REGIME WITH INHALED ANTIBIOTICS IS SWITCHED TO AZTREONAM LYSINE IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC PULMONARY INFECTION CAUSED BY PSEUDOMONAS AERUGINOSA
Sole A; (...); Casado MA
Meeting Abstract. 10.1016/j.jval.2014.08.1659. 2014
Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan
Ribera, E; (...); Hernandez-Novoa, B
Article. 10.1016/j.eimc.2016.11.015. 2018
Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.
Torres Martínez E; (...); Vento M
Article. 10.1016/j.anpedi.2020.03.009. 2020
EFFECT OF CYP3A5 GENOTYPE ON TACROLIMUS DOSE REQUIREMENT, NEPHROTOXICITY AND ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES
Rojas, L.; (...); Alino, S. F.
Article. 2013
Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies
Rojas L; (...); Aliño SF
Article. 10.1038/tpj.2014.38. 2015
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment
Palanques-Pastor T; (...); Poveda Andrés JL
Article. 10.1159/000517813. 2021
Effects of COVID-19 Lockdown on Heart Failure Patients: A Quasi-Experimental Study.
Sánchez-González JL; (...); Marques-Sule E
Article. 10.3390/jcm12227090. 2023
EFFECTS OF POLYMORPHIMS OF CYP3A5 AND ABCB1 GENES ON CHRONIC NEPHROPATHY: COHORT STUDY
Rojas, L.; (...); Alino, S. F.
Article. 2013
Efficacy and Safety of de Novo and Early Use of Extended-release Tacrolimus in Heart Transplantation.
Gonzalez-Vilchez, F; (...); de Prada, JAV
Article. 10.1016/j.rec.2017.03.014. 2018
Eisenmenger syndrome: is it the same entity in adulthood and pediatric age?
Playan Escribano, J.; (...); Del Cerro Marin, M. J.
Meeting Abstract. 2021
eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice
Bonanad, S; (...); Megias-Vericat, JE
Meeting Abstract. 2018
EPIDEMIOLOGICAL STUDY OF TRICUSPID REGURGITATION AFTER CARDIAC TRANSPLANTATION. DOES IT INFLUENCE SURVIVAL?
Lopez-Vilella, R; (...); Almenar-Bonet, L
Meeting Abstract. 2021
Epidemiological Study of Tricuspid Regurgitation After Cardiac Transplantation. Does it Influence Survival?
Lopez-Vilella, Raquel; (...); Almenar-Bonet, Luis
Article. 10.3389/ti.2022.10197. 2022
Epidemiology of supplemental oxygen in patients with pulmonary hypertension.
Torres-Castro, Rodrigo; (...); Blanco, Isabel
Article. 10.1111/resp.14821. 2024
Essential ECG clues in patients with congenital heart disease and arrhythmias
Cano, O; (...); Martinez-Dolz, L
Article. 10.1016/j.jelectrocard.2016.08.005. 2017
ESTIMATION OF THE ECONOMIC AND SOCIAL BURDEN OF PULMONARY ARTERIAL HYPERTENSION IN SPAIN
Zozaya, N.; (...); Hidalgo Vega, A.
Meeting Abstract. 2022
Estudio de utilizacion de boceprevir y telaprevir para el tratamiento de la hepatitis C cronica.
Marrero-Álvarez P; (...); Poveda-Andrés JL
Abstract of Published Item. 10.7399/FH.2014.38.1.1128. 2014
EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN
Badia, F. J.; (...); Shepherd, J.
Meeting Abstract. 2019
Evaluation of a near-zero fluoroscopic approach for catheter ablation in patients with congenital heart disease
Cano, O; (...); Mart?nez-Dolz, L
Article. 10.1007/s10840-018-0467-3. 2019
Evolutionary description of heart transplantation and heart-lung transplantation in congenital heart disease
Donoso Trenado, V.; (...); Almenar Bonet, L.
Meeting Abstract. 2022
Evolutionary Description of Heart Transplantation and Heart-Lung Transplantation in Congenital Heart Disease.
Donoso Trenado, Victor; (...); Almenar-Bonet, Luis
Article. 10.1016/j.transproceed.2022.10.006. 2022
Evolving Indications for Heart-Lung Transplant in Spain.
Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis
Article. 10.1016/j.transproceed.2022.10.003. 2022
Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 10.1016/j.gastrohep.2014.05.004. 2014
Experience of Home Delivery Program in Haemophilia Through an Association of Patients
Megias Vericat, J. E.; (...); Bonanad Boix, S.
Meeting Abstract. 2017
Experience with COVID-19 heart transplant patients in a tertiary hospital
Donoso, V.; (...); Almenar Bonet, L.
Article. 2021
Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life
Esteban-Fernandez, Alberto; (...); Lopez-Vilella, Raquel
Article. 10.1002/ehf2.13976. 2022
EXPERTS CONSENSUS ON THE FUTURE OF RARE DISEASES CARE AND ORPHAN DRUGS ACCESS IN SPAIN: A DELPHI STUDY
Paz S; (...); Urcelay J
Meeting Abstract. 10.1016/j.jval.2015.09.2016. 2015
Exploratory analysis for the implementation of antineoplastic logarithmic dose banding
Albert-Mari, A; (...); Poveda-Andres, JL
Article. 10.1007/s11096-018-0714-9. 2018
EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY
F, de Andres-Nogales; (...); Martinez, M.
Meeting Abstract. 2019
Facilitators and barriers to perform physical activity in patients post-heart transplantation: a qualitative study.
Klompstra L; (...); Marques-Sule E
Article. 10.1093/eurjcn/zvae144. 2024
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease
Beltran, B; (...); Nos, P
Article. 10.1159/000492626. 2019
Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report
Fernandez-Sanchez, M; (...); Poveda-Andres, JL
Article. 10.1002/bdr2.1942. 2021
Fontan Circulation in Adult Patients: Acoustic Radiation Force Impulse Elastography as a Useful Tool for Liver Assessment.
Melero-Ferrer JL; (...); Rueda-Soriano J
Article. 10.1177/2150135114530172. 2014
Fontan procedure: imaging of normal post-surgical anatomy and the spectrum of cardiac and extracardiac complications
Navarro-Aguilar V; (...); Leiva-Salinas C
Review. 10.1016/j.crad.2014.10.005. 2015
Gender differences in heart transplantation: Twenty-five year trends in the nationwide Spanish heart transplant registry.
García-Cosío MD; (...); Delgado-Jiménez JF
Article. 10.1111/ctr.14096. 2020
Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy
Herrer I; (...); Rivera M
Article. 10.1186/s12920-015-0088-y. 2015
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.
Plaza J; (...); Moret-Tatay I
Article. 10.3390/ijms25073717. 2024
Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population
Bosó V; (...); Aliño SF
Article. 10.1097/FTD.0b013e3182a94e65. 2014
Golgi ribbon integrity in human patients with chronic heart failure
Gimenez Escamilla, I.; (...); Tarazon, E.
Meeting Abstract. 2021
Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis
Editorial Material. 2022
Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12568. 2017
Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study
Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units
Article. 10.7399/fh.10935. 2018
Hazardous drugs: new challenges, new opportunities.
Valero García S; (...); Poveda Andrés JL
Article. 10.7399/fh.2016.40.2.10462. 2016
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Solana-Altabella, Antonio; (...); Martinez-Cuadron, David
Article. 10.3390/cancers14081921. 2022
Heart failure patients with reduced left ventricular ejection fraction, who reached 100% target dose of beta-blockers in randomized and observational studies
Artola, MJMJO; (...); Esteban, A
Meeting Abstract. 2018
Heart transplantation and heart-lung transplantation in congenital heart disease. experience in a tertiary referral hospital
Donoso, V.; (...); Almenar Bonet, L.
Meeting Abstract. 2021
Heart transplantation and metabolic syndrome: which calcineurin inhibitor most promotes its development?
Martinez-Dolz, L.; (...); Salvador-Sanz, A.
Article. 2013
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.
El-Qutob D; (...); Carrera-Hueso FJ
Article. 10.1016/j.hrtlng.2022.02.003. 2022
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo
Article. 10.7399/fh.11729. 2022
Hospitalization budget impact during the COVID-19 pandemic in Spain.
Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.
Article. 10.1186/s13561-021-00340-0. 2021
How can artificial intelligence optimize value-based contracting?
Poveda, Jose Luis; (...); Medrano, Ignacio H.
Letter. 10.1186/s40545-022-00475-3. 2022
How much does right ventricular dysfunction influence the elevation of NT-proBNP in patients with acute heart failure?
Vilella, RRL; (...); Bonet, LA
Meeting Abstract. 2018
Hyperkalemia in heart failure patients: current challenges and future prospects
Lopez-Vilella, R; (...); Almenar-Bonet, L
Review. 10.2147/RRCC.S75680. 2016
Hypertonic saline solution with furosemide for the treatment of congestive symptoms of acute heart failure
Carrillo, D; (...); Almenar, L
Meeting Abstract. 2018
Identification and validation of plasma micrornas involved in venous and arterial thrombosis
Ramon, L. A.; (...); Navarro, S.
Meeting Abstract. 2015
IDENTIFICATION OF A PLASMA MICRORNAS PROFILE INVOLVED IN ARTERIAL THROMBOSIS
Navarro, S.; (...); Espana, F.
Meeting Abstract. 10.1016/S0049-3848(14)50273-3. 2014
Identification of sarcomere serum biomarkers for non-invasive diagnosis of cardiac rejection
Perez Carrillo, L.; (...); Esther Rosello-Lleti, E.
Meeting Abstract. 2021
Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1080/10428194.2016.1231405. 2017
Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart (R) in patients with multiple sclerosis
Edo Solsona MD; (...); Poveda Andrés JL
Article. 10.2147/PPA.S127508. 2017
IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART (R) IN PATIENTS WITH MULTIPLE SCLEROSIS
Edo-Solsona, M.; (...); Poveda-Andres, J.
Meeting Abstract. 10.1016/j.jval.2016.09.512. 2016
Impact of an antimicrobial stewardship program on critical haematological patients.
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.7399/fh.2017.41.4.10709. 2017
Impact of basal heart rate on long-term prognosis of heart transplant patients.
Melero-Ferrer JL; (...); Salvador-Sanz A
Article. 10.1111/tri.12082. 2013
Impact of Circulatory Assistance in the Early Evolution After Heart Transplantation. Unicentric Experience.
Martinez-Lauwers, Ana; (...); Martinez-Dolz, Luis
Article. 10.1016/j.transproceed.2021.08.041. 2021
Impact of circulatory assistance in the early evolution after heart transplantation: unicentric experience.
Martinez-Lauwers, A.; (...); Martinez-Dolz, L.
Meeting Abstract. 2020
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1080/10428194.2020.1839650. 2020
Impact of comorbidities in outpatients with chronic heart failure
Carrillo, D; (...); Almenar, L
Meeting Abstract. 2018
Impact of donor-recipient age on cardiac transplant survival. Subanalysis of the Spanish Heart Transplant Registry.
Lopez-Vilella, Raquel; (...); Almenar-Bonet, Luis
Article. 10.1016/j.recesp.2020.02.018. 2020
Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction.
Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis
Article. 10.1002/ehf2.13753. 2022
Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1038/tpj.2017.19. 2018
Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1097/FPC.0000000000000286. 2017
Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation
Ruiz J; (...); Aliño SF
Article. 10.3390/ijms160920168. 2015
Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019
Badia X; (...); Hernández C
Article. 10.1186/s13023-020-01507-4. 2020
Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Meeting Abstract. 2015
Impact of voriconazole plasma concentrations on treatment response in critically ill patients
Ruiz, J; (...); Ramirez, P
Article. 10.1111/jcpt.12817. 2019
Impact on Survival of Heart and Heart-Lung Transplantation in Patients With Cyanotic and Noncyanotic Congenital Heart Diseases.
Donoso-Trenado, Victor; (...); Almenar-bonet, Luis
Article. 10.1016/j.transproceed.2024.12.005. 2024
Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases
Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL
Article. 10.7399/fh.11262. 2020
Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1159/000478969. 2018
Implication of Sphingolipid Metabolism Gene Dysregulation and Cardiac Sphingosine-1-Phosphate Accumulation in Heart Failure.
Perez-Carrillo, Lorena; (...); Tarazon, Estefania
Article. 10.3390/biomedicines10010135. 2022
Implication of sphingolipid metabolism gene dysregulation and cardiac sphingosine-1-phosphate accumulation in heart failure
Perez Carrillo, L.; (...); Tarazon, E.
Meeting Abstract. 2021
Implications of Molecular Markers in Brain-Dead Donors in Primary Graft Dysfunction and Rejection After Heart Transplantation: The Potential Role of Preconditioning
Herrador-Galindo, L.; (...); Moreno-Gonzalez, G.
Meeting Abstract. 10.1016/j.healun.2024.02.526. 2024
Incidence and factors related to vasoplegia in the early postoperatory period of orthotopic heart transplantation
Vilella, RRL; (...); Bonet, LA
Meeting Abstract. 2018
Incidence of Development of Obesity After Heart Transplantation According to the Calcineurin Inhibitor
López-Vilella R; (...); Montero-Argudo A
Article. 10.1016/j.transproceed.2014.11.025. 2015
Incidence of Development of Obesity After Heart Transplantation According to the Calcineurin Inhibitor (vol 47, pg 127, 2015)
Lopez-Vilella, R.; (...); Montero-Argudo, A.
Article. 10.1016/j.transproceed.2015.09.023. 2015
Incompatibility of undiluted busulfan injection with a needle-free valve
Cueto-Sola, M; (...); Poveda-Andres, JL
Letter. 10.2146/ajhp140111. 2014
Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285.
Bosó V; (...); Aliño SF
Article. 10.1124/dmd.112.047977. 2013
Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Vericat, JEM; (...); Bonanad, S
Meeting Abstract. 2018
Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables
Megias-Vericat, Juan Eduardo; (...); Bonanad, Santiago
Meeting Abstract. 10.1182/blood.V128.22.3802.3802. 2016
Infective endocarditis in patients with heart transplantation.
Martínez-Sellés M; (...); Muñoz P
Article. 10.1016/j.ijcard.2020.12.018. 2021
Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies
Megías-Vericat JE; (...); Aliño SF
Review. 10.1038/tpj.2014.80. 2015
Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy
Bastida, G; (...); Nos, P
Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1080/10428194.2017.1323267. 2017
Influence of Gender in Advanced Heart Failure Therapies and Outcome Following Transplantation.
García-Cosío MD; (...); Delgado JF
Article. 10.3389/fcvm.2021.630113. 2021
Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.
Ruiz J; (...); Poveda JL
Article. 10.23736/S0026-4946.18.04978-2. 2018
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1097/FPC.0000000000000431. 2021
Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Meeting Abstract. 2015
Influence of the type of circulatory/ventricular assistance in the primary graft failure and heart transplantation mortality
Vilella, RRL; (...); Bonet, LA
Meeting Abstract. 2018
Influence on kinesiophobia by disability, physical, and behavioural variables after a heart transplantation.
Marques-Sule E; (...); Bäck M
Article. 10.1093/eurjcn/zvab134. 2022
Interdisciplinary recommendations document to improve adherence in patients with chronic inflammatory diseases: Adhing recommendations.
Bermejo San José F; (...); Sanromán-Álvarez L
Article. 10.7399/fh.2016.40.5.10180. 2016
Intermittent administration of levosimendan ambulatory in patients with advanced chronic heart failure: experience in our center
Martin, PA; (...); Bonet, LA
Meeting Abstract. 2018
Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12842. 2019
Intravenous sildenafil in right ventricular dysfunction with pulmonary hypertension following a heart transplant.
Bonet LA; (...); Sanz AS
Article. 10.5301/HEART.2014.12492. 2014
Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
Solana-Altabella A; (...); Poveda JL
Article. 10.1177/1078155220904410. 2020
Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19
Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP
Article. 10.1136/ejhpharm-2020-002322. 2020
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
Pozo-Rosich P; (...); Irimia P
Article. 10.1186/s10194-024-01747-w. 2024
Is the Benefit of Treating Iron Deficiency Greater in Acute Heart Failure with Renal Dysfunction?
Lopez-Vilella, Raquel; (...); Almenar Bonet L
Article. 10.3390/life13040915. 2023
Is the benefit of treating iron deficiency greater in acute heart failure with renal dysfunction?
Lopez Vilella, R. Raquel; (...); Bonet, L. Almenar
Meeting Abstract. 2023
Is there a variation of CA-125 levels with changes in glomerular filtration rate in patients with heart failure?
Carrillo, D; (...); Almenar, L
Meeting Abstract. 2018
Is there changes in the diuretic response to hypertonic saline plus furosemide depending on the type of heart failure?
Carrillo, D; (...); Almenar, L
Meeting Abstract. 2018
Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula
Article. 10.3390/antibiotics13080706. 2024
Kinesiophobia and associated variables in patients with heart failure.
Sentandreu-Mano, Trinidad; (...); Marques-Sule, Elena
Article. 10.1093/eurjcn/zvad072. 2023
Kinesiophobia in heart transplantation patients: a cross-sectional study with a special focus in sex differences
Moreno Segura, N.; (...); Marques-Sule, E.
Meeting Abstract. 2023
Kinesiophobia, physical activity and quality of life in patients with heart failure: a cross-sectional study
Sempere-Rubio, N.; (...); Marques-Sule, E.
Meeting Abstract. 2022
Lack of agreement between the exercise variables to assess the risk in PAH
Martinez Menaca, Amaya; (...); Escribano Subias, Pliar
Meeting Abstract. 10.1183/13993003.congress-2021.OA142. 2021
Left atrial strain in adults after the arterial switch operation for transposition of the great arteries.
Buendia-Fuentes, Francisco; (...); Rueda, Joaquin
Article. 10.1111/echo.15750. 2024
Left ventricular systolic performance in adults after arterial switch operation. Echocardiographic data from EPOCH-ASO: a multi-centric international registry
Fernandez, V. Gonzalez; (...); Dos, L.
Meeting Abstract. 2023
Lesion-specific risk for sudden cardiac death or life-threatening ventricular arrhythmias in adult congenital heart disease
Gallego Garcia De Vinuesa, P.; (...); Oliver, J. M.
Meeting Abstract. 2019
Long term outcome of single ventricle physiology with pulmonary restriction not undergoing Fontan repair
Buendia, F; (...); Dos, L
Meeting Abstract. 2020
Long-term changes in left ventricular ejection fraction depending on the type of heart failure
Vilella, RRL; (...); Bonet, LA
Meeting Abstract. 2018
Long-term study of prevalence and evolution of tricuspid regurgitation after orthotopic heart transplantation
Lopez Vilella, R.; (...); Almenar Bonet, L.
Meeting Abstract. 2022
Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.
Megías-Vericat JE; (...); Poveda-Andrés JL
Article. 2021
Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.
Vázquez Polo A; (...); Vázquez Costa JF
Article. 10.20960/nh.03946. 2022
Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
Bonanad, S; (...); Santos, S
Article. 10.1007/s12325-021-01853-0. 2021
Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.
Rojas LE; (...); Aliño SF
Article. 10.1097/FPC.0b013e3283642fb3. 2013
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Article. 10.3390/cancers14030596. 2022
Metabolic syndrome in heart transplantation: impact on survival and renal function.
Martínez-Dolz L; (...); Montero JA
Article. 10.1111/tri.12149. 2013
Metyrapone as treatment in the neonatal McCune-Albright syndrome
de Mingo, Carmen; (...); Garcia-Robles, Ana
Article. 10.1515/jpem-2020-0036. 2020
Molecular Alterations of Nucleocytoplasmic Transport in Patients on the Heart Transplantation Waiting List and Its Correlation With the Severity and Etiology of Heart Failure.
Ezzitouny, M.; (...); Martinez-Dolz, L.
Article. 10.1016/j.transproceed.2018.12.013. 2019
Monitoring coagulation factors during surgery. A systematic review
Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11766. 2021
Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).
Valero-García S; (...); Delgado-Sánchez O
Article. 10.7399/fh.11655. 2021
Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.
Fernandez-Megia, MJ; (...); Poveda Andrés JL
Article. 10.7399/fh.10793. 2018
Mortality after the first hospital admission for acute heart failure de novo vs. acutely decompensated heart failure with reduced ejection fraction
Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.
Meeting Abstract. 2023
Mortality After the First Hospital Admission for Acute Heart Failure, De Novo Versus Acutely Decompensated Heart Failure With Reduced Ejection Fraction.
Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis
Article. 10.1016/j.amjcard.2023.03.008. 2023
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Gomez-Cebrian, N; (...); Pineda-Lucena, A
Review. 10.3390/cancers13184544. 2021
Musculoskeletal disorders in men and women with heart transplantation. A cross-sectional study
Segura, N. Moreno; (...); Marques-Sule, E.
Meeting Abstract. 2023
Myocardial and lymphocytic expression of eNOS and nNOS before and after heart transplantation: relationship to clinical status.
Vicente D; (...); D'Ocon P
Article. 10.1016/j.lfs.2013.05.025. 2013
N. VICTOR JIMENEZ TORRES (1942-2015) IN MEMORIAM
Climente Martí M, Poveda Andrés JL, Culebras J
Biographical-Item. 10.3305/nh.2015.32.4.9704. 2015
National consensus on the cardiological treatment and follow-up of Kawasaki disease
Sombrero, HR; (...); SECPCC
Article. 10.1016/j.anpedi.2018.04.003. 2018
National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)
Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel
Correction. 10.7399/fh.11740. 2021
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
New challenges of advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2023.11.008. 2024
Non-invasive diagnosis of cardiac rejection using small non-coding RNAs
Gimenez-Escamilla, I.; (...); Rosello-Lleti, E.
Meeting Abstract. 2022
Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial.
Núñez J; (...); Bayés-Genís A
Article. 10.1161/JAHA.119.014254. 2020
Noninvasive Liver Assessment in Adult Patients With Fontan Circulation Using Acoustic Radiation Force Impulse Elastography and Hepatic Magnetic Resonance Imaging.
Buendia-Fuentes, F; (...); Martinez-Dolz, L
Article. 10.1177/2150135117732674. 2018
Novel Imaging Techniques for Heart Failure.
Melero-Ferrer JL; (...); Martinez-Dolz L
Article. 10.15420/cfr.2015:29:2. 2016
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.
Poveda JL; (...); Badia X
Article. 10.1186/s13023-022-02610-4. 2023
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Review. 10.3390/biology12091159. 2023
Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice
Bonanad, S; (...); Poveda, JL
Meeting Abstract. 2018
OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT
Flores-Moreno, S.; (...); Gil, A.
Meeting Abstract. 2024
Paclitaxel and carboplatin treatment for advanced ovarian cancer during pregnancy.
Ruiz Ramos J; (...); Poveda JL
Article. 10.1159/000360691. 2013
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
Garcia-Robles, Ana; (...); Carrascosa, MA
Article. 10.3389/fped.2020.00372. 2020
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Correction. 10.3389/fped.2021.834454. 2022
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project
Morillo-Verdugo, R; (...); Diaz-Olmo, J
Article. 10.7399/fh.11719. 2021
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.
Morillo-Verdugo R; (...); Díaz-Olmo J
Article. 2021
Peripheral access ultrafiltration as a treatment for cardiorenal syndrome with inadequate diuretic response. Initial experience
Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar
Letter. 10.1016/j.recesp.2022.04.017. 2023
Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy
Margusino-Framiñán L; (...); Morillo-Verdugo R
Article. 10.7399/fh.11498. 2020
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis
Article. 10.3390/ijms26041760. 2025
Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.2174/1389200218666171101124931. 2018
Pharmacogenomics and the treatment of acute myeloid leukemia
Megías-Vericat JE; (...); Aliño SF
Review. 10.2217/pgs-2016-0055. 2016
Pharmacometabolomics by NMR in Oncology: A Systematic Review.
Gómez-Cebrián N; (...); Pineda-Lucena A
Article. 10.3390/ph14101015. 2021
Pharmacotherapeutic management of advanced therapy medicinal products
Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia
Article. 10.7399/fh.13036. 2022
Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.
Calleja Hernández MÁ; (...); Aragon, B
Article. 10.7399/fh.2017.41.1.10463. 2017
Phenotypic patterns of right ventricular dysfunction: analysis by cardiac magnetic imaging.
J Sánchez-Lázaro I; (...); Salvador-Sanz A
Article. 10.4081/hi.2013.e3. 2013
Physical activity enjoyment, exercise motivation, and physical activity in patients with heart failure: A mediation analysis.
Klompstra L; (...); Marques-Sule E
Article. 10.1177/02692155221103696. 2022
Physical Activity In Haemophilia: Hemorrhagic Risk And Factor Levels (myPKFiT)
Querol-Fuentes, F; (...); Bonanad, S
Meeting Abstract. 2017
Pilot evaluation of home delivery programme in haemophilia
Megias-Vericat, JE; (...); Poveda-Andres, JL
Article. 10.1111/jcpt.12718. 2018
PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS
Vericat, JEM; (...); Iorio, A
Meeting Abstract. 2020
Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation.
Lozano-Edo S; (...); Martínez-Dolz L
Article. 10.1097/TP.0000000000003798. 2021
Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis
Megías-Vericat JE; (...); Aliño SF
Letter. 10.1038/tpj.2015.79. 2016
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
Article. 10.1080/10428194.2018.1474462. 2019
Practical Requirements for the Development of an Advanced Cardiorenal Unit
Almenar-Bonet, Luis; (...); Sanchez-Perez, Pilar
Review. 10.1159/000536104. 2024
Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process
Valero, S; (...); Poveda, JL
Article. 10.1016/j.yrtph.2018.03.001. 2018
Predicting Sarcopenia and Frailty Risk in Patients Post Heart Transplantation.
Sentandreu-Mano, Trinidad; (...); Machado, Felipe V C
Article. 10.1111/ctr.70027. 2025
Predicting sudden cardiac death in adults with congenital heart disease.
Oliver JM; (...); Spanish ACHD Network
Article. 10.1136/heartjnl-2020-316791. 2021
PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019
Preliminary experience on the usefulness of immunoglobulin A as a biomarker in patients with decompensated heart failure
Lopez-Vilella, R.; (...); Almenar Bonet, L.
Meeting Abstract. 2021
Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.
García-Robles A; (...); Aguar-Carrascosa M
Letter. 10.1016/j.anpedi.2020.06.008. 2021
Preparation and administration of insulin infusions in neonatology: A national survey.
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Article. 10.1016/j.anpede.2020.06.015. 2021
Presence and evolution of multiple pulmonary nodules with halo sign detected by computerized tomography in advanced heart failure
Vilella, RRL; (...); Bonet, LA
Meeting Abstract. 2018
Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Poveda Andrés JL, Edo Solsona MD
Article. 10.1016/j.farma.2023.06.0131130. 2024
Prevalence of fragmented QRS complex and factors related with its occurrence
Martinez-Dolz, L.; (...); Almenar-Bonet, L.
Article. 2014
Prevalence of Tricuspid Regurgitation After Orthotopic Heart Transplantation and Its Evolution in the Follow-up Period: A Long-Term Study.
Lopez-Vilella, Raquel; (...); Almenar-Bonet, Luis
Article. 10.1016/j.transproceed.2022.09.009. 2022
Prevalence, characteristics, and phenotype associated with tachycardiomyopathy in a cohort of patients first hospitalized for heart failure with reduced ejection fraction
Otero Garcia, O.; (...); Gonzalez-Juanatey, J. R.
Meeting Abstract. 2024
Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review
Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11780. 2021
Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. COMFE registry
Vega, D. Garcia; (...); Gonzalez-Juanatey, J. R.
Meeting Abstract. 10.1093/eurheartj/ehae666.1187. 2024
Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. implications for their clinical management. COMFE registry
Garcia Vega, D. David; (...); Gonzalez-Juanatey, J. R.
Meeting Abstract. https://doi.org/10.1093/eurheartj/ehae666.1187. 2024
Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
PROGNOSTIC IMPACT OF TRANSPORTER GENE POLYMORPHISMS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA ADULTS
Megias Vericat, J. E.; (...); Sanz, M. A.
Article. 2015
Prognostic implications of hypo and hyperkalaemia in acute heart failure with reduced ejection fraction. Analysis of cardiovascular mortality and hospital readmissions.
Laymito-Quispe RDP; (...); Almenar-Bonet, Luis
Article. 10.1016/j.medcli.2021.03.037. 2022
Prostaglandin Injection After Arterial Compromise Related to Hyaluronic Acid Filler
Megias-Vericat, JE; (...); Poveda, JL
Letter. 10.1097/DSS.0000000000001046. 2017
Pulmonary arterial hypertension associated with pretricuspid shunts: risk profile and survival.
Calvo-Asensio, Maria; (...); Rueda Soriano, Joaquin
Article. 10.1016/j.rec.2024.04.016. 2024
Pulmonary hypertension and congenital heart disease: medical treatment and risk factors for survival
Escribano, JP; (...); Subias, PE
Meeting Abstract. 2020
Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker
Perez-Alenda, S; (...); Querol, F
Letter. 10.1111/hae.13388. 2018
Reduction in alert fatigue in an assisted electronic prescribing system, through the Lean Six Sigma methodology.
Cuéllar Monreal MJ; (...); Poveda Andrés JL
Article. 10.7399/fh.2017.41.1.10434. 2017
Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIRE.
Ufnal, Marcin; (...); Rosenkranz, Stephan
Article. 10.1002/ehf2.15203. 2025
Repetitive ambulatory doses of levosimendan for patients as bridge to heart transplant. Findings from the LEVO-T registry.
De Juan Baguda, J. Javier; (...); Gonzalez-Costello, J.
Meeting Abstract. 2022
Repetitive ambulatory levosimendan as a bridge to heart transplantation.
Baguda, Javier De Juan; (...); Gonzalez-Costello, Jose
Article. 10.1016/j.rec.2023.07.002. 2023
Reversal of anticoagulation with idarucizumab. Initial experience in heart and heart-and-lung transplantation
Vilella, RL; (...); Bonet, LA
Meeting Abstract. 2018
Role of DNMT3B system in human ischemic hearts
Perez Carrillo, L.; (...); Rosello-Lleti, E.
Meeting Abstract. 2021
Safety and feasibility of conduction system pacing in patients with congenital heart disease
Cano, O; (...); Vijayaraman, P
Article. 10.1111/jce.15213. 2021
Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.
Article. 10.1111/ajt.14580. 2018
Sarcomere ACTC1 and MYO18A serum expression levels detect acute cellular rejection in cardiac transplant patients
Perez Carrillo, L.; (...); Rosello-Lleti, E.
Meeting Abstract. 2021
SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11565. 2020
Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol.
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/1078155212457964. 2013
Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice
Aguas Peris M; (...); Nos, P
Article. 10.1097/MIB.0000000000001182. 2017
Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice
Meeting Abstract. 2017
Severity of Donor Transmitted Coronary Artery Disease and Survival after Heart Transplantation. Results from the Donor Coronary Artery Disease (DONOR-CAD) Study
Couto-Mallon, D.; (...); Crespo-Leiro, M. G.
Meeting Abstract. 2023
Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial-IRON Trial.
Del Canto I; (...); Núñez J
Article. 10.1161/JAHA.121.022214. 2022
Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation
Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.
Article. 10.1016/j.healun.2014.01.392. 2014
Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction
Otero Garcia, O. Oscar; (...); Gonzalez-Juanatey, J. R.
Meeting Abstract. https://doi.org/10.1093/eurheartj/ehae666.836. 2024
Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction
Garcia, O. Otero; (...); Gonzalez-Juanatey, J. R.
Meeting Abstract. 10.1093/eurheartj/ehae666.836. 2024
SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization
Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis
Article. 10.1111/jcpt.13703. 2022
SNPs and taxane toxicity in breast cancer patients
Bosó V; (...); Aliño SF
Article. 10.2217/PGS.14.127. 2014
Sodium-glucose cotransporter 2 inhibitors reduce cardiovascular events in acute heart failure. A real-world analysis.
Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar
Article. 10.1016/j.ejim.2022.06.008. 2022
Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
Cantón R; (...); Solé A
Article. 10.1016/j.arbres.2014.09.021. 2015
Spanish Heart Transplant Registry. 29th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure
Gonzalez-Vilchez, F; (...); Representation Equipos Espanoles T
Article. 10.1016/j.recesp.2018.07.020. 2018
Spanish Heart Transplant Registry. 30th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure (1984-2018)
Gonzalez-Vilchez, F; (...); Abella-Anton, R
Article. 10.1016/j.rec.2019.09.005. 2019
Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology.
González-Vilchez F; (...); Groba Marco MDV
Article. 10.1016/j.rec.2020.06.035. 2020
Study design and rationale of the pAtients pResenTing with cOngenital heaRt dIseAse Register (ARTORIA-R)
Sinning, Christoph; (...); Kirchhof, Paulus
Article. 10.1002/ehf2.13574. 2021
Study of molecules involved in cellular traffic in advanced heart failure: are there differences in the nivels of these molecules between ischemic heart disease and idiopathic dilated cardiomyopathy?
Ezzitouny, M.; (...); Martinez-Dolz, L.
Meeting Abstract. 2018
Study on the Linezolid Prescription According to the Approval of Indication in a University Hospital
Pérez-Cebrián M; (...); Llopis-González A
Article. 2015
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Megías-Vericat JE; (...); Montesinos P
Review. 10.3390/pharmaceutics14040878. 2022
Technology Usage, Physical Activity, and Motivation in Patients With Heart Failure and Heart Transplantation.
Deka P; (...); Marques-Sule E
Article. 10.1097/CIN.0000000000001049. 2023
The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity
Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar
Article. 10.1007/s00431-022-04628-z. 2022
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A; (...); Gil A
Article. 10.1016/j.yebeh.2022.108711. 2022
The coronavirus disease pandemic among adult congenital heart disease patients and the lessons learnt - results of a prospective multicenter european registry.
Ruperti-Repilado, Francisco Javier; (...); Schwerzmann, Markus
Article. 10.1016/j.ijcchd.2022.100428. 2023
The economic burden of pulmonary arterial hypertension in Spain.
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.1186/s12890-022-01906-2. 2022
The Female Sex Confers Different Prognosis in Heart Failure: Same Mortality but More Readmissions.
López-Vilella R; (...); Almenar Bonet L
Article. 10.3389/fcvm.2021.618398. 2021
The Role of Conventional and Right-Sided ECG Screening for Subcutaneous ICD in a Tetralogy of Fallot Population
Alonso, P; (...); Sancho-Tello, MJ
Article. 10.1111/pace.13017. 2017
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Badia, Xavier; (...); Valles, Joan-Antoni
Article. 10.1186/s13023-024-03324-5. 2024
The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus
Torrent-Farnell, J; (...); Lizan, L
Article. 10.1016/j.healthpol.2018.03.002. 2018
Therapeutic approach in heart failure with poor diuretic response. Peripheral ultrafiltration vs. conventional treatment
Lopez-Vilella, R.; (...); Almenar Bonet, L.
Meeting Abstract. 2023
Therapeutic approach in heart failure with poor diuretic response: peripheral ultrafiltration vs. conventional treatment.
López-Vilella R; (...); Almenar Bonet L
Article. 10.1002/ehf2.14386. 2023
Three cases of psychosis after use of sacubitril/valsartan.
Perez-Rosello, Victor; (...); Almenar-Bonet, Luis
Letter. 10.1016/j.recesp.2020.05.019. 2021
Time course and predictors for neoaortic root dilatation and neoaortic valve regurgitation during adult life after arterial switch operation.
Rueda Soriano, Joaquin; (...); Gallego, Pastora
Article. 10.1016/j.recesp.2020.01.031. 2020
Tolvaptan in hyponatremic patients with heart failure: initial experience
Martinez-Dolz, L.; (...); Salvador-Sanz, A.
Article. 2013
Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.
Marques MR; (...); Mangas-Sanjuan V
Article. 10.1111/apa.14944. 2020
Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy
Del Rio-Bermudez, C; (...); Poveda, JL
Editorial Material. 10.1186/s40545-020-00276-6. 2020
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.
Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis
Article. 10.1136/ejhpharm-2024-004184. 2024
Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs.
Megías Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.rx.2015.01.008. 2015
Transient pulmonary nodules with halo sign in patients with advanced heart failure: a report of two cases.
López-Vilella R; (...); Bonet LA
Article. 10.1016/j.clinimag.2019.11.008. 2020
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature
Lizan, L; (...); Polanco, C
Review. 10.2147/PPA.S67253. 2014
Ultrafiltracion de acceso periferico como tratamiento del sindrome cardiorrenal con insuficiente respuesta diuretica. Experiencia inicial.
Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar
Art Exhibit Review. 10.1016/j.rec.2022.04.013. 2022
Uncontrolled asistole donation. Impact on primary graft failure and heart transplantation survival
Donoso Trenado, V.; (...); Almenar Bonet, L.
Meeting Abstract. 2022
Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?
Bejar, S; (...); Mateu, PN
Meeting Abstract. 2020
Univentricular hearts not undergoing Fontan: the type of palliation matters.
Gordon, Blanca; (...); Subira, Laura Dos
Article. 10.1016/j.rec.2023.03.001. 2024
Unveiling the prognostic journey: renal function trajectories in 'de novo' heart failure with reduced ejection fraction - insights from a cohort study and their impact on patient outcomes
Garcia, O. Otero; (...); Gonzalez-Juanatey, J. R.
Meeting Abstract. 10.1093/eurheartj/ehae666.835. 2024
Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy
Garcia, SV; (...); Andres, JLP
Article. 10.1016/j.yrtph.2018.10.002. 2018
Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick Type C patients
García-Robles AA; (...); Poveda JL
Letter. 10.1016/j.jns.2016.04.048. 2016
Use of a "CNI holidays" strategy in acute renal dysfunction late after heart transplant. Report of two cases.
Article. 2014
USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Dominguez Hernandez, L.; (...); Gomez Segui, I
Meeting Abstract. 2019
Use of idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. a multicentric experience in spain
Crespo-Leiro, MGMG; (...); Almenar-Bonet, L
Meeting Abstract. 2019
Use of Idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. A multicentric experience in Spain.
Crespo-Leiro MG; (...); Almenar-Bonet L
Article. 10.1111/ctr.13748. 2019
Use of tolvaptan in patients with hyponatremia due to heart failure: initial experience.
Rodríguez-de Muñoz YM; (...); Salvador-Sanz A
Letter. 10.1016/j.rec.2012.09.010. 2013
Usefulness of biomarkers to predict prognosis after heart transplant
Lopez-Vilella, Raquel; (...); Boneta, Luis Almenar
Article. 10.1016/j.rec.2024.04.019. 2024
Usefulness of Immunoglobulin A in Patients With Decompensated Heart Failure: Is It a Future Marker of Congestion? Preliminary Experience.
Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar
Article. 10.1016/j.transproceed.2021.07.051. 2021
Usefulness of short-term peripheral ambulatory ultrafiltration in heart failure refractory to diuretics. Initial experience.
Guerrero Cervera B; (...); Almenar Bonet L
Article. 10.1016/j.medcli.2023.04.008. 2023
Usefulness of the biomarker CA125 in the diagnosis of acute cellular rejection in allogeneic heart transplantation
Lopez-Vilella, RLV; (...); Bonet, LABA
Meeting Abstract. 2019
Utility of nucleocytoplasmic transport as a marker in critical heart failure with circulatory assistance as a bridge to transplant
Ezzitouny, M.; (...); Marinez-Dolz, L.
Meeting Abstract. 2020
Utility of the Biomarker CA125 in the Diagnosis of Cellular Rejection in Allogeneic Heart Transplantation.
Lopez-Vilella, R; (...); Bonet, LA
Article. 10.1016/j.transproceed.2021.07.058. 2021
Validation of the usefulness of 2-dimensional strain parameters to exclude acute rejection after heart transplantation: a multicenter study.
Goirigolzarri Artaza, Josebe; (...); Segovia Cubero, Javier
Article. 10.1016/j.recesp.2020.01.033. 2020
VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA
Poveda, J. L.; (...); Lizan, L.
Meeting Abstract. 2023
Value of SERCA2a as a Biomarker for the Identification of Patients with Heart Failure Requiring Circulatory Support.
Ezzitouny M; (...); Martínez-Dolz L
Article. 10.3390/jpm11111122. 2021
Value of the Electrocardiogram as a Predictor of Right Ventricular Dysfunction in Patients With Chronic Right Ventricular Volume Overload.
Alonso P; (...); Salvador A
Article. 10.1016/j.rec.2014.04.019. 2015
Variation in diuretic requirement after peripheral ultrafiltration in heart failure with diuretic resistance
Lopez Vilella, R.; (...); Almenar Bonet, L.
Meeting Abstract. 2022
Variations in the medical treatment of heart failure during admission for decompensation
Lopez Vilella, R.; (...); Almenar Bonet, L.
Meeting Abstract. 2022
Well-Being, Physical Activity, and Social Support in Octogenarians with Heart Failure during COVID-19 Confinement: A Mixed-Methods Study
Marques-Sule, Elena; (...); Luis Cabanillas-Garcia, Juan
Article. 10.3390/ijerph192215316. 2022
What clinical parameters are associated with the prescription at hospital discharge of all medications with prognostic improvement? Analysis in de novo heart failure with reduced ejection fraction
Lopez Vilella, R. Raquel; (...); Bonet, Almenar
Meeting Abstract. 2024
What factors are associated with myocardial recovery following admission for acute heart failure? Study in patients with de novo diagnosis and reduced left ventricular ejection fraction
Donoso Trenado, V.; (...); Almenar-Bonet, L.
Meeting Abstract. 2024
What motivates heart transplantation patients to exercise and engage in physical activity? A network analysis.
Marques-Sule, Elena; (...); Machado, Felipe V C
Article. 10.1093/eurjcn/zvad051. 2023
Why Iron Deficiency in Acute Heart Failure Should Be Treated: A Real-World Clinical Practice Study.
Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis
Article. 10.3390/life12111828. 2022